Biblio
A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer. PLoS Biol. 2023;21(9):e3002295.
. Therapeutic strategies to induce ERα in luminal breast cancer to enhance tamoxifen efficacy. Endocr Relat Cancer. 2019.
Taking a Toll on Self-Renewal: TLR-Mediated Innate Immune Signaling in Stem Cells. Trends Neurosci. 2016.
. The SNP rs755622 is associated with immune activation in glioblastoma. JCI Insight. 2023.
Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2018.
New T-cell therapies for brain metastasis, CD133 in the driver's seat. Clin Cancer Res. 2023.
. Lyn Facilitates Glioblastoma Cell Survival under Conditions of Nutrient Deprivation by Promoting Autophagy. PLoS One. 2013;8(8):e70804.
Let the Guard Down: cAMP Activators Can Improve Immunotherapy in GBM. Cancer Immunol Res. 2023:OF1-OF2.
. JAM-A functions as a female microglial tumor suppressor in glioblastoma. Neuro Oncol. 2020.
Development of a Cx46 Targeting Strategy for Cancer Stem Cells. Cell Rep. 2019;27(4):1062-1072.e5.
Decoding the cancer stem cell hypothesis in glioblastoma. CNS Oncol. 2013;2(4).
. Cx25 contributes to leukemia cell communication and chemosensitivity. Oncotarget. 2015.
Cisplatin induces stemness in ovarian cancer. Oncotarget. 2016.
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014.
Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion. Stem Cells. 2016.
Cancer stem cells: moving past the controversy. CNS Oncol. 2013;2(6):465-467.
.